Literature DB >> 11890677

Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death.

Hiroshi Nakagawa1, Masaaki Wachi, Je-Tae Woo, Masanori Kato, Shinya Kasai, Fuminori Takahashi, In-Seon Lee, Kazuo Nagai.   

Abstract

To propose candidates for the prevention or treatment of osteoporosis, we have screened compounds naturally in food for their ability to regulate the differentiation and function of osteoclasts. One of the major green tea flavonoids, (-)-epigallocatechin-3-gallate (EGCG), was found to induce apoptotic cell death of osteoclast-like multinucleated cells after 24 h treatment in a dose-dependent manner (25-100 microM), whereas osteoblasts were not affected. In the present study, we report for the first time a novel cell-death-inducing mechanism triggered by EGCG. The induction of apoptosis by EGCG was suppressed by pretreatment of catalase or calcitonin. It was also suppressed by Fe(III) and Fe(II) chelators. Furthermore, EGCG promoted the reduction of Fe(III) into Fe(II), and the combination of EGCG/Fe(III)/H(2)O(2) induced single-strand DNA breakage in a cell free system. These results indicate that the Fenton reaction is primarily involved in EGCG-induced osteoclastic cell death. (C)2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11890677     DOI: 10.1006/bbrc.2002.6622

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  40 in total

1.  Inhibitory effect of (-)-epigallocatechin gallate on titanium particle-induced TNF-α release and in vivo osteolysis.

Authors:  Shan Jin; Ju Young Park; Jung Min Hong; Tae Ho Kim; Hong In Shin; Eui Kyun Park; Shin Yoon Kim
Journal:  Exp Mol Med       Date:  2011-07-30       Impact factor: 8.718

2.  Bone status in a mouse model of genetic hemochromatosis.

Authors:  P Guggenbuhl; P Fergelot; M Doyard; H Libouban; M-P Roth; Y Gallois; G Chalès; O Loréal; D Chappard
Journal:  Osteoporos Int       Date:  2010-10-26       Impact factor: 4.507

3.  Protective effect of green tea polyphenols on bone loss in middle-aged female rats.

Authors:  C-L Shen; P Wang; J Guerrieri; J K Yeh; J-S Wang
Journal:  Osteoporos Int       Date:  2007-12-15       Impact factor: 4.507

Review 4.  Tea and bone health: steps forward in translational nutrition.

Authors:  Chwan-Li Shen; Ming-Chien Chyu; Jia-Sheng Wang
Journal:  Am J Clin Nutr       Date:  2013-10-30       Impact factor: 7.045

5.  EGCG ameliorates the hypoxia-induced apoptosis and osteogenic differentiation reduction of mesenchymal stem cells via upregulating miR-210.

Authors:  Yiyan Qiu; Yang Chen; Tenghui Zeng; Weizhuang Guo; Wenyu Zhou; Xinjian Yang
Journal:  Mol Biol Rep       Date:  2016-01-16       Impact factor: 2.316

6.  Role of (-)-epigallocatechin-3-gallate in the osteogenic differentiation of human bone marrow mesenchymal stem cells: An enhancer or an inducer?

Authors:  Pan Jin; Muyan Li; Guojie Xu; Kun Zhang; L I Zheng; Jinmin Zhao
Journal:  Exp Ther Med       Date:  2015-06-16       Impact factor: 2.447

7.  Epigallocatechin-3-Gallate Inhibition of Myeloperoxidase and Its Counter-Regulation by Dietary Iron and Lipocalin 2 in Murine Model of Gut Inflammation.

Authors:  Beng San Yeoh; Rodrigo Aguilera Olvera; Vishal Singh; Xia Xiao; Mary J Kennett; Bina Joe; Joshua D Lambert; Matam Vijay-Kumar
Journal:  Am J Pathol       Date:  2016-03-08       Impact factor: 4.307

8.  Consumption of green tea extract results in osteopenia in growing male mice.

Authors:  Urszula T Iwaniec; Russell T Turner; Sung I Koo; Rouminder Kaur; Emily Ho; Carmen P Wong; Richard S Bruno
Journal:  J Nutr       Date:  2009-08-26       Impact factor: 4.798

Review 9.  Green tea and bone metabolism.

Authors:  Chwan-Li Shen; James K Yeh; Jay J Cao; Jia-Sheng Wang
Journal:  Nutr Res       Date:  2009-07       Impact factor: 3.315

10.  Modulatory properties of various natural chemopreventive agents on the activation of NF-kappaB signaling pathway.

Authors:  Woo-Sik Jeong; In-Wha Kim; Rong Hu; Ah-Ng Tony Kong
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.